HUTCHMED gains wider China drug coverage on NRDL, insurance

    Adlai Nortye (ANL) licenses AN9025 to ASK Pharm in Greater China

    Adlai Nortye (NASDAQ: ANL) entered an exclusive license agreement with ASK Pharm for its pan‑RAS (ON) inhibitor AN9025 in mainland China, Hong Kong and Macao on Dec 29, 2025. ASK Pharm gains rights to develop, manufacture, and commercialize AN9025 in the Licensed Territory while Adlai Nortye retains worldwide rights elsewhere. The deal…

    Read More
    Daily Mirror

    ‘Doctors missed my cancer 9 times – I could’ve died because they didn’t listen’

    When Amanda Harbron first went to the doctors with persistent abdominal pain she was dismissed and told it was probably ‘women’s issues’. When she was finally properly diagnosed it was almost too late 08:00, 22 Nov 2025Updated 09:31, 22 Nov 2025 Amanda Harbron’s symptoms were dismissed as ‘women’s issues’. For years, 54-year-old Amanda from Gateshead,…

    Read More
    Eradicate 'deaths from breast cancer'

    Eradicate ‘deaths from breast cancer’

    About 170,000 women in the United States are living with metastatic breast cancer — or cancer that has spread to other organs — and eventually leads to death. Now, a team led in part by oncologists from the Yale cancer hospital is looking to drastically change that outcome through new clinical trials that will begin…

    Read More